Hiroyuki Kawagishi

Kawasaki, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Global trends in drug development using alternatives to animal testing

Global trends in drug development using alternatives to animal testing

Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica

Published: September 02, 2026

Preface

Preface

Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica

Published: May 06, 2026

Non-clinical safety assessments using human cells for pediatric drug development

Non-clinical safety assessments using human cells for pediatric drug development

Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica

Published: May 06, 2026

β-Arrestin-biased activation of type I angiotensin II receptors improves prognosis of murine pediatric heart failure.

β-Arrestin-biased activation of type I angiotensin II receptors improves prognosis of murine pediatric heart failure.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: November 20, 2025

In Vitro Assessment of Drug-Induced Liver Injury Using Three-Dimensional Cultured HepaSH Cells Derived From Chimeric Mouse Model With Humanized Liver.

In Vitro Assessment of Drug-Induced Liver Injury Using Three-Dimensional Cultured HepaSH Cells Derived From Chimeric Mouse Model With Humanized Liver.

Journal: Journal of applied toxicology : JAT

Published: May 09, 2025

Development of a Novel Therapeutic for Pediatric Heart Failure Targeting Angiotensin II Receptor

Development of a Novel Therapeutic for Pediatric Heart Failure Targeting Angiotensin II Receptor

Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

Published: April 02, 2025

Challenges in Development of Appropriate Drugs for Children

Challenges in Development of Appropriate Drugs for Children

Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

Published: April 02, 2025

Cardiotoxicity Assessment of EGFR Tyrosine Kinase Inhibitors Using Human iPS Cell-Derived Cardiomyocytes and FDA Adverse Events Reporting System.

Cardiotoxicity Assessment of EGFR Tyrosine Kinase Inhibitors Using Human iPS Cell-Derived Cardiomyocytes and FDA Adverse Events Reporting System.

Journal: Clinical and translational science

Published: March 10, 2025

Safety and efficacy assessments using human iPS cell-derived cardiomyocytes

Safety and efficacy assessments using human iPS cell-derived cardiomyocytes

Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica

Published: January 05, 2025

Regeneration of Nonhuman Primate Hearts With Human Induced Pluripotent Stem Cell-Derived Cardiac Spheroids.

Regeneration of Nonhuman Primate Hearts With Human Induced Pluripotent Stem Cell-Derived Cardiac Spheroids.

Journal: Circulation

Published: April 26, 2024

Cardiotoxicity risk assessment of anti-cancer drugs and future perspectives

Cardiotoxicity risk assessment of anti-cancer drugs and future perspectives

Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica

Published: March 03, 2024

Contractility assessment using aligned human iPSC-derived cardiomyocytes.

Contractility assessment using aligned human iPSC-derived cardiomyocytes.

Journal: Journal of pharmacological and toxicological methods

Published: February 08, 2024

Showing 1-12 of 18

Last Updated: 09/26/2026